| 1. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 2-2
&NA;,
Preview
|
PDF (792KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 2. |
Group A streptococcal infections increasing cause of concern |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 3-3
&NA;,
Preview
|
PDF (775KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 3. |
Stagnation in OTC drug growth |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 4-4
Robert Short,
Preview
|
PDF (837KB)
|
|
摘要:
Government healthcare reforms and the increasing desire of patients to treat themselves have led world experts to predict explosive growth of over-the-counter (OTC) medicines. According to Eric Décosterd from Zyma SA, in Nyon, Switzerland, ‘some of these experts were even predicting that around the year 2000 the self-medication market would be almost as big as the prescription business’. It now appears that such predictions may be way off the mark. Delegates at the conference, ‘Continuing Pharmaceutical Growth in the Face of Ongoing US and European Healthcare Reforms’, organised by IIR Ltd, heard possible explanations for the turn of fortune for OTC pharmaceuticals. The conference was held in London, UK, in March.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 4. |
Views in the news- A weekly update on bottom-line conclusions and recommendations from the literature - |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 5-5
&NA;,
Preview
|
PDF (831KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 5. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 6-6
&NA;,
Preview
|
PDF (760KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 6. |
Risperidonedoes it give ‘enough bang for the buck’? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 7-8
Greg L Plosker,
Preview
|
PDF (1458KB)
|
|
摘要:
Risperidone is expensive but, apparently, nottooexpensive. Recent Canadian guidelines suggest a cut-off point for how much spending can be justified per quality-adjusted life-year (QALY) gained when comparing old treatments with new. And a recent cost-utility study conducted by Janssen researchers has determined that risperidone comes close enough to this cut-off point to be recommended as treatment for schizophrenia. The results of this study were discussed at the 20th Annual Canadian Society of Hospital Pharmacists (Western Branches)[Banff, Alberta, Canada; March 1994].
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 7. |
Lifestyle improvements at a low cost |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 8-8
&NA;,
Preview
|
PDF (678KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 8. |
‘Breakthrough’ malaria vaccine described |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 9-9
&NA;,
Preview
|
PDF (760KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 9. |
Putting a damper on inactivated HIV vaccine development? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 10-10
&NA;,
Preview
|
PDF (826KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
| 10. |
Cloning of the CD26 gene - implications for HIV infection and beyond |
| |
Inpharma Weekly,
Volume &NA;,
Issue 933,
1994,
Page 11-11
Rachel Webber,
Preview
|
PDF (784KB)
|
|
摘要:
Talk about CD26, and the controversy surrounding its possible role as a coreceptor for HIV cell entry immediately comes to mind. Yet, the functions of the molecule go far beyond this. In fact, researchers in Australia are more interested in its role in liver function and disease. But the work of these researchers could also have implications for HIV research as they have succeeded in cloning the CD26 gene.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
首页
